Stelios Papadopoulos - Insider Trading & Ownership

Location
3 Somerset Drive South, Great Neck, NY
Summary
The estimated net worth of Stelios Papadopoulos is at least $56.2M dollars as of June 27, 2025. Stelios Papadopoulos is the Director of EXELIXIS, INC. and owns shares of EXELIXIS, INC. (EXEL) stock worth about $46.6M. Stelios Papadopoulos is the Director of BIOGEN INC. and owns shares of BIOGEN INC. (BIIB) stock worth about $9.5M. Stelios Papadopoulos is the Director of Ovid Therapeutics Inc. and owns shares of Ovid Therapeutics Inc. (OVID) stock worth about $112K.
Signature
/s/ Christopher Aker, Attorney-in-Fact
All Insider Reports
All Insider Reports

Ownership of Stelios Papadopoulos

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
EXEL EXELIXIS, INC. Director $46.6M -$1.62M -3.36% May 29, 2025
BIIB BIOGEN INC. Director $9.5M Jun 15, 2022
OVID Ovid Therapeutics Inc. Director $112K Mar 3, 2025
RGLS Regulus Therapeutics Inc. Director $0 Jun 25, 2025

Insider Transactions Reported by Stelios Papadopoulos:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.